Treatment of stable chronic obstructive pulmonary disease

Stephen I. Rennard

Research output: Contribution to journalArticle

76 Scopus citations

Abstract

Chronic obstructive pulmonary disease (COPD) is a readily diagnosable disorder that responds to treatment. Smoking cessation can reduce symptoms and prevent progression of disease. Bronchodilator therapy is key in improvement of lung function. Three classes of bronchodilators - β agonists, anticholinergics, and theophylline - are available and can be used individually or in combination. Inhaled glucocorticoids can also improve airflow and can be combined with bronchodilators. Inhaled glucocorticoids, in addition, might reduce exacerbation frequency and severity as might some bronchodilators. Effective use of pharmacotherapy in COPD needs integration with a rehabilitation programme and successful treatment of co-morbidities, including depression and anxiety. Treatment for stable COPD can improve the function and quality of life of many patients, could reduce admissions to hospital, and has been suggested to improve survival.

Original languageEnglish (US)
Pages (from-to)791-802
Number of pages12
JournalLancet
Volume364
Issue number9436
DOIs
StatePublished - Aug 28 2004

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Treatment of stable chronic obstructive pulmonary disease'. Together they form a unique fingerprint.

  • Cite this